Ascend Wellness Holdings (AAWH) EBITDA Margin (2020 - 2026)
Ascend Wellness Holdings (AAWH) recorded quarterly EBITDA Margin of 2.18% in Q1 2026, up 115.29% quarter-over-quarter from 14.24% in Q4 2025, and up 24.0% on a YoY basis from 1.76% in Q1 2025.
Ascend Wellness Holdings (AAWH) EBITDA Margin (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' EBITDA Margin history runs 7 years deep, the most recent figure standing at 2.18% for Q1 2026.
- In Q1 2026, EBITDA Margin rose 24.0% year-over-year to 2.18%; the TTM figure through Mar 2026 stood at 3.46% (down 431.0% YoY), while the FY2025 annual figure was 3.4%, down 424.0% from the prior year.
- EBITDA Margin was 2.18% for Q1 2026 at Ascend Wellness Holdings, up from 14.24% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 4.8% in Q4 2022 to a low of 17.37% in Q1 2022.
- Historically, EBITDA Margin has averaged 1.34% across 5 years, with a median of 0.22% in 2023.
- The sharpest annual moves came in 2022 and 2025: EBITDA Margin surged 3100 bps in 2022, then sank 1873 bps in 2025.
- A 5-year view of EBITDA Margin shows it stood at 4.8% in 2022, then plunged by 92 bps to 0.4% in 2023, then jumped by 1014 bps to 4.48% in 2024, then sank by 418 bps to 14.24% in 2025, then surged by 115 bps to 2.18% in 2026.
- The last three EBITDA Margin figures came in at 2.18% (Q1 2026), 14.24% (Q4 2025), and 1.06% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -1.01% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 22.74% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -170.35% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -16.25% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 21.55% |
| 10 | Ascend Wellness Holdings | - | - | 44.88 Mn | 2.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.18% |
| Dec 31, 2025 | -14.24% |
| Sep 30, 2025 | -1.06% |
| Jun 30, 2025 | -0.79% |
| Mar 31, 2025 | 1.94% |
| Dec 31, 2024 | 4.48% |
| Sep 30, 2024 | -1.71% |
| Jun 30, 2024 | -1.08% |
| Mar 31, 2024 | 1.81% |
| Dec 31, 2023 | 0.40% |
| Sep 30, 2023 | 2.51% |
| Jun 30, 2023 | -6.49% |
| Mar 31, 2023 | 0.22% |
| Dec 31, 2022 | 4.80% |
| Sep 30, 2022 | 2.23% |
| Jun 30, 2022 | -0.62% |
| Mar 31, 2022 | -17.37% |
| Dec 31, 2021 | -0.83% |
| Sep 30, 2021 | 12.30% |
| Jun 30, 2021 | 4.68% |